What does Intercept Pharmaceuticals do?
We are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), primary sclerosing cholangitis (PSC) and biliary atresia.
How many employees does Intercept Pharmaceuticals have?
Compare ICPT With Other Stocks
| Intercept Pharmaceuticals Annual Number of Employees | |
|---|---|
| 2019 | 583 |
| 2018 | 483 |
| 2017 | 507 |
| 2016 | 456 |
Who owns Intercept Pharmaceuticals?
Top 10 Owners of Intercept Pharmaceuticals Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| The Vanguard Group, Inc. | 7.83% | 2,324,590 |
| BlackRock Fund Advisors | 6.65% | 1,976,936 |
| Fidelity Management & Research Co… | 5.96% | 1,770,794 |
| Eventide Asset Management LLC | 2.69% | 800,000 |
Is intercept Pharmaceuticals a buy?
Intercept Pharmaceuticals has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 5 buy ratings, 6 hold ratings, and 1 sell rating.
What is Obeticholic acid used for?
Obeticholic acid is used alone or in combination with ursodiol (Actigall, Urso) to treat primary biliary cholangitis (PBC; a type of liver disease that destroys bile ducts, which allows bile to stay in the liver and cause damage) in people who cannot take ursodiol or in people who were not treated successfully with …
Will Intercept Pharmaceuticals stock go up?
Stock Price Forecast The 14 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 82.00 and a low estimate of 10.00. The median estimate represents a +58.63% increase from the last price of 15.13.
Should I buy Icpt Zacks?
The VGM Score are a complementary set of indicators to use alongside the Zacks Rank….Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.75% |
| 2 | Buy | 18.15% |
| 3 | Hold | 9.70% |
| 4 | Sell | 5.35% |
Who manufactures Obeticholic acid?
Headquartered in Hyderabad, India, Dr. Reddy’s Laboratories is one of the leading Active Pharmaceutical Ingredients (API) manufacturers and suppliers globally for Obeticholic Acid API. Dr.
How much does Obeticholic acid cost?
Table 6CDR Cost Comparison Table for the Management of Primary Biliary Cholangitis
| Drug / Comparator | Strength | Price ($) |
|---|---|---|
| Obeticholic acid | 5 mg 10 mg | 98.6301a |
| Ursodeoxycholic acid (Ursodiol generics) | 250 mg 500 mg | 0.7636 1.4483 |
Is Intercept Pharma a buy?
Should I buy ICPT stock?
Out of 8 analysts, 1 (12.5%) are recommending ICPT as a Strong Buy, 2 (25%) are recommending ICPT as a Buy, 4 (50%) are recommending ICPT as a Hold, 0 (0%) are recommending ICPT as a Sell, and 1 (12.5%) are recommending ICPT as a Strong Sell. What is ICPT’s earnings growth forecast for 2022-2024?
Is Intercept Pharmaceuticals a buy?
Is ICPT a good investment?
The financial health and growth prospects of ICPT, demonstrate its potential to perform inline with the market. It currently has a Growth Score of D. Recent price changes and earnings estimate revisions indicate this would be a good stock for momentum investors with a Momentum Score of B.
What drug class is Obeticholic acid?
Obeticholic acid is in a class of medications called farnesoid X receptor agonists. It works by decreasing the production of bile in the liver and increasing the removal of bile from the liver.
Is Obeticholic acid available in India?
Ahmedabad based Cadila Pharmaceuticals has launched Obetocad in India, a generic version of Ocaliva® (Obeticholic Acid) primarily used for the treatment of Primary Biliary Cholangitis (PBC).
Should I buy ICPT Zacks?
Will Icpt go up?
The 14 analysts offering 12-month price forecasts for Intercept Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 82.00 and a low estimate of 10.00. The median estimate represents a +77.25% increase from the last price of 13.54.
Is ICPT a buy or sell?
The Historical Cash Flow Growth is the longer-term (3-5 year annualized) growth rate of the cash flow change….Momentum Scorecard. More Info.
| Zacks Rank | Definition | Annualized Return |
|---|---|---|
| 1 | Strong Buy | 24.75% |
| 2 | Buy | 18.15% |
| 3 | Hold | 9.70% |
| 4 | Sell | 5.35% |